Sphera Funds Management Ltd.
- SEC CIK
- 0001496201
- 最新申報
- 2026/8/14
2026 年第 1 季持倉
持倉截至 2026/3/31，2026/5/15 申報。只含多頭部位，變化是跟 2025 年第 4 季比股數。
- 持股檔數
- 92
- 較 2025 年第 4 季 −2
- 總值
- $5.81 億
- 較 2025 年第 4 季 +$1.03 億 (+21.5%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| MLYSMineralys Therapeutics, Inc. | COM | 1,339,971 | $3,630 萬 | 6.2% | +890,968+198.4% | 加碼 | 歷史 |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 1,136,975 | $3,425 萬 | 5.9% | +13,450+1.2% | 加碼 | 歷史 |
| TSEMTower Semiconductor Ltd | SHS NEW | 145,735 | $2,557 萬 | 4.4% | +23,222+19.0% | 加碼 | 歷史 |
| NVMINova Ltd. | COM | 53,366 | $2,318 萬 | 4.0% | +5,520+11.5% | 加碼 | 歷史 |
| BBIOBridgeBio Pharma, Inc. | COM | 245,246 | $1,821 萬 | 3.1% | +137,500+127.6% | 加碼 | 歷史 |
| BIIBBiogen Inc. | COM | 92,526 | $1,696 萬 | 2.9% | −2,212−2.3% | 減碼 | 歷史 |
| RAREUltragenyx Pharmaceutical Inc. | COM | 809,333 | $1,696 萬 | 2.9% | +508,710+169.2% | 加碼 | 歷史 |
| SNDXSyndax Pharmaceuticals Inc | COM | 724,563 | $1,693 萬 | 2.9% | −38,000−5.0% | 減碼 | 歷史 |
| COGTCogent Biosciences, Inc. | COM | 416,340 | $1,602 萬 | 2.8% | +37,840+10.0% | 加碼 | 歷史 |
| SNYSanofi | SPONSORED ADR | 269,515 | $1,299 萬 | 2.2% | +30,000+12.5% | 加碼 | 歷史 |
| AZNAstraZeneca PLC | ADR | 62,530 | $1,233 萬 | 2.1% | −5,000−7.4% | 減碼依 1 比 2 拆股換算 | 歷史 |
| FOLDAmicus Therapeutics, Inc. | COM | 603,377 | $872.5 萬 | 1.5% | −55,000−8.4% | 減碼 | 歷史 |
| CLBTCellebrite DI Ltd. | ORDINARY SHARES | 631,521 | $870.2 萬 | 1.5% | +631,521 | 新進 | 歷史 |
| APLSApellis Pharmaceuticals, Inc. | COM | 214,914 | $864.6 萬 | 1.5% | −36,047−14.4% | 減碼 | 歷史 |
| PANWPalo Alto Networks Inc | Stock | 52,800 | $846.5 萬 | 1.5% | +52,800 | 新進 | 歷史 |
| LLYEli Lilly & Co | Stock | 9,040 | $831.5 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| BCRXBiocryst Pharmaceuticals Inc | COM | 866,464 | $824.9 萬 | 1.4% | +28,575+3.4% | 加碼 | 歷史 |
| CAMTCamtek Ltd | ORD | 53,020 | $803.8 萬 | 1.4% | +13,522+34.2% | 加碼 | 歷史 |
| BMRNBiomarin Pharmaceutical Inc | COM | 139,900 | $790.3 萬 | 1.4% | −7,100−4.8% | 減碼 | 歷史 |
| CLDXCelldex Therapeutics, Inc. | COM NEW | 243,575 | $772.6 萬 | 1.3% | +3,811+1.6% | 加碼 | 歷史 |
| ORAOrmat Technologies, Inc. | COM | 68,250 | $763.9 萬 | 1.3% | +68,250 | 新進 | 歷史 |
| XENEXenon Pharmaceuticals Inc. | COM | 127,000 | $738.5 萬 | 1.3% | +127,000 | 新進 | 歷史 |
| SLNOSoleno Therapeutics Inc | COM | 216,281 | $724.1 萬 | 1.2% | +79,967+58.7% | 加碼 | 歷史 |
| TNGXTango Therapeutics, Inc. | COM | 343,563 | $718.7 萬 | 1.2% | −201,000−36.9% | 減碼 | 歷史 |
| JNJJohnson & Johnson | Stock | 28,831 | $704.7 萬 | 1.2% | −7,000−19.5% | 減碼 | 歷史 |
| Solaredge Technologies, Inc.83417MAE4 | NOTE 2.250% 7/0 | 4,000,000 | $691.0 萬 | 1.2% | 00.0% | 不變 | – |
| IMTXImmatics N.V. | SHS | 696,105 | $685.0 萬 | 1.2% | −165,000−19.2% | 減碼 | 歷史 |
| TRVITrevi Therapeutics, Inc. | COM | 574,029 | $684.8 萬 | 1.2% | −24,505−4.1% | 減碼 | 歷史 |
| ORICOric Pharmaceuticals, Inc. | COM | 537,628 | $681.2 萬 | 1.2% | −466,750−46.5% | 減碼 | 歷史 |
| MAZEMaze Therapeutics, Inc. | COM | 227,343 | $678.6 萬 | 1.2% | +155,500+216.4% | 加碼 | 歷史 |
| GSKGSK plc | ADR | 122,000 | $673.3 萬 | 1.2% | 00.0% | 不變 | 歷史 |
| AMZNAmazon Com Inc | Stock | 31,940 | $665.2 萬 | 1.1% | +31,940 | 新進 | 歷史 |
| ABBVAbbVie Inc. | Stock | 30,256 | $658.0 萬 | 1.1% | +5,000+19.8% | 加碼 | 歷史 |
| AAOIApplied Optoelectronics, Inc. | COM | 73,400 | $620.9 萬 | 1.1% | +73,400 | 新進 | 歷史 |
| ELVNEnliven Therapeutics, Inc. | COM | 153,265 | $600.8 萬 | 1.0% | −73,500−32.4% | 減碼 | 歷史 |
| MRKMerck & Co., Inc. | Stock | 48,600 | $584.6 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| VORVor Biopharma Inc. | COM NEW | 321,917 | $574.3 萬 | 1.0% | −88,500−21.6% | 減碼 | 歷史 |
| ACADAcadia Pharmaceuticals Inc | COM | 256,202 | $570.3 萬 | 1.0% | +44,000+20.7% | 加碼 | 歷史 |
| NVSNovartis AG | ADR | 37,000 | $565.2 萬 | 1.0% | 00.0% | 不變 | 歷史 |
| ELDNEledon Pharmaceuticals, Inc. | COM | 1,772,131 | $545.8 萬 | 0.9% | −360,000−16.9% | 減碼 | 歷史 |
| ENPHEnphase Energy, Inc. | Stock | 142,419 | $538.5 萬 | 0.9% | −44,081−23.6% | 減碼 | 歷史 |
| RVMDRevolution Medicines, Inc. | COM | 55,110 | $535.9 萬 | 0.9% | +2,610+5.0% | 加碼 | 歷史 |
| PFEPfizer Inc | Stock | 186,000 | $522.3 萬 | 0.9% | +100,000+116.3% | 加碼 | 歷史 |
| BHVNBiohaven Ltd. | COM | 594,000 | $502.5 萬 | 0.9% | +594,000 | 新進 | 歷史 |
| FBRXForte Biosciences, Inc. | COM NEW | 184,984 | $479.1 萬 | 0.8% | −885−0.5% | 減碼 | 歷史 |
| HELPHelus Pharma Inc. | COM NEW | 987,090 | $473.8 萬 | 0.8% | +161,514+19.6% | 加碼 | 歷史 |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 9,040 | $473.2 萬 | 0.8% | +5,740+173.9% | 加碼 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 94,265 | $463.4 萬 | 0.8% | −64,000−40.4% | 減碼 | 歷史 |
| NVONovo Nordisk A S | ADR | 120,677 | $443.5 萬 | 0.8% | +5,000+4.3% | 加碼 | 歷史 |
| MDWDMediWound Ltd. | SHS NEW | 273,192 | $440.1 萬 | 0.8% | +42,845+18.6% | 加碼 | 歷史 |
| KODKodiak Sciences Inc. | COM | 114,796 | $437.6 萬 | 0.8% | −60,704−34.6% | 減碼 | 歷史 |
| ZBIOZenas BioPharma, Inc. | COM | 214,334 | $419.0 萬 | 0.7% | +214,334 | 新進 | 歷史 |
| PMNProMIS Neurosciences Inc. | COM SHS | 325,591 | $413.5 萬 | 0.7% | +313,784+2,657.6% | 加碼 | 歷史 |
| RLAYRelay Therapeutics, Inc. | COM | 408,436 | $406.4 萬 | 0.7% | +408,436 | 新進 | 歷史 |
| SVRASavara Inc | COM | 739,164 | $403.6 萬 | 0.7% | −439,000−37.3% | 減碼 | 歷史 |
| WVEWave Life Sciences, Inc. | SHS | 548,272 | $397.5 萬 | 0.7% | +140,106+34.3% | 加碼 | 歷史 |
| CRVSCorvus Pharmaceuticals, Inc. | COM | 247,961 | $362.8 萬 | 0.6% | −159,748−39.2% | 減碼 | 歷史 |
| OVIDOvid Therapeutics Inc. | COM | 1,622,828 | $360.3 萬 | 0.6% | +1,622,828 | 新進 | 歷史 |
| IRONDisc Medicine, Inc. | COM | 53,538 | $342.3 萬 | 0.6% | +53,538 | 新進 | 歷史 |
| UPBUpstream Bio, Inc. | COM | 358,000 | $322.2 萬 | 0.6% | +358,000 | 新進 | 歷史 |
| ACOGAlpha Cognition Inc. | COM NEW | 567,616 | $311.6 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| PALIPalisade Bio, Inc. | COM | 1,733,471 | $303.4 萬 | 0.5% | +1,549,371+841.6% | 加碼 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 160,594 | $291.2 萬 | 0.5% | −232,300−59.1% | 減碼 | 歷史 |
| CLYMClimb Bio, Inc. | COM | 419,247 | $287.2 萬 | 0.5% | −513,000−55.0% | 減碼 | 歷史 |
| ZIMZIM Integrated Shipping Services Ltd. | SHS | 105,950 | $279.2 萬 | 0.5% | −30,055−22.1% | 減碼 | 歷史 |
| MSLESatellos Bioscience Inc. | COM | 489,207 | $275.4 萬 | 0.5% | +489,207 | 新進 | 歷史 |
| SEDGSolaredge Technologies, Inc. | COM | 52,836 | $269.7 萬 | 0.5% | −143,700−73.1% | 減碼 | 歷史 |
| AMGNAmgen Inc | Stock | 7,500 | $263.9 萬 | 0.5% | 00.0% | 不變 | 歷史 |
| CYTKCytokinetics Inc | COM NEW | 39,817 | $262.4 萬 | 0.5% | −51,900−56.6% | 減碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 50,800 | $244.9 萬 | 0.4% | +9,800+23.9% | 加碼 | 歷史 |
| KURAKura Oncology, Inc. | COM | 295,522 | $240.3 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| GENBGenerate Biomedicines, Inc. | COM SHS | 185,000 | $231.3 萬 | 0.4% | +185,000 | 新進 | 歷史 |
| IBITiShares Bitcoin Trust ETF | ETF | 59,505 | $228.6 萬 | 0.4% | +29,450+98.0% | 加碼 | 歷史 |
| CTNMContineum Therapeutics, Inc. | CL A | 173,475 | $226.6 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| TENXTenax Therapeutics, Inc. | COM NEW | 136,015 | $217.5 萬 | 0.4% | −54,096−28.5% | 減碼 | 歷史 |
| PRLDPrelude Therapeutics Inc | COM | 558,339 | $191.0 萬 | 0.3% | +435,587+354.9% | 加碼 | 歷史 |
| ASNDAscendis Pharma A/S | SPONSORED ADR | 8,000 | $183.0 萬 | 0.3% | −3,000−27.3% | 減碼 | 歷史 |
| VSTMVerastem, Inc. | COM NEW | 343,678 | $182.1 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| VYGRVoyager Therapeutics, Inc. | COM | 469,761 | $181.3 萬 | 0.3% | +130,000+38.3% | 加碼 | 歷史 |
| STTKShattuck Labs, Inc. | COM | 280,786 | $180.5 萬 | 0.3% | +85,574+43.8% | 加碼 | 歷史 |
| EVMNEvommune, Inc. | COM SHS | 78,234 | $179.9 萬 | 0.3% | −87,913−52.9% | 減碼 | 歷史 |
| BIOABioAge Labs, Inc. | COM | 86,518 | $151.3 萬 | 0.3% | −156,517−64.4% | 減碼 | 歷史 |
| ORGOOrganogenesis Holdings Inc. | COM | 550,000 | $130.3 萬 | 0.2% | +550,000 | 新進 | 歷史 |
| CRISCuris Inc | COM | 1,994,937 | $109.2 萬 | 0.2% | +1,994,937 | 新進 | 歷史 |
| BMYBristol Myers Squibb Co | Stock | 17,500 | $106.1 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| CTMXCytomX Therapeutics, Inc. | COM | 220,000 | $103.4 萬 | 0.2% | +220,000 | 新進 | 歷史 |
| NICENICE Ltd. | SPONSORED ADR | 5,611 | $61.9 萬 | 0.1% | +5,611 | 新進 | 歷史 |
| HOWLWerewolf Therapeutics, Inc. | COM | 626,810 | $52.2 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| SKYESkye Bioscience, Inc. | COM NEW | 678,928 | $41.7 萬 | 0.1% | +200,000+41.8% | 加碼 | 歷史 |
| DTILPrecision Biosciences Inc | COM NEW | 40,000 | $22.0 萬 | <0.1% | −356,116−89.9% | 減碼 | 歷史 |
| APREAprea Therapeutics, Inc. | COM NEW | 270,000 | $20.6 萬 | <0.1% | 00.0% | 不變 | 歷史 |
| FHTXFoghorn Therapeutics Inc. | COM | 12,224 | $5.84 萬 | <0.1% | +12,224 | 新進 | 歷史 |
選擇權（4 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
2025 年第 4 季之後清倉（21 檔）
2025 年第 4 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2025 年第 4 季股數 | 2025 年第 4 季市值 | 2025 年第 4 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ANNXAnnexon, Inc. | COM | 1,316,212 | $660.7 萬 | 1.4% | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 355,725 | $465.6 萬 | 1.0% | 歷史 |
| AMDAdvanced Micro Devices Inc | Stock | 18,040 | $386.3 萬 | 0.8% | 歷史 |
| TARAProtara Therapeutics, Inc. | COM STK | 650,000 | $346.4 萬 | 0.7% | 歷史 |
| AVGOBroadcom Inc. | Stock | 9,755 | $337.6 萬 | 0.7% | 歷史 |
| ESLTElbit Systems Ltd | Stock | 5,340 | $308.5 萬 | 0.6% | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 124,000 | $235.2 萬 | 0.5% | 歷史 |
| JANXJanux Therapeutics, Inc. | COM | 157,840 | $217.8 萬 | 0.5% | 歷史 |
| TSHATaysha Gene Therapies, Inc. | COM SHS | 368,146 | $202.5 萬 | 0.4% | 歷史 |
| PHVSPharvaris N.V. | COM | 63,953 | $177.5 萬 | 0.4% | 歷史 |
| VRNSVaronis Systems Inc | COM | 52,500 | $172.2 萬 | 0.4% | 歷史 |
| VTYXVentyx Biosciences, Inc. | COM | 180,114 | $162.6 萬 | 0.3% | 歷史 |
| DAWNDay One Biopharmaceuticals, Inc. | Stock | 145,371 | $135.5 萬 | 0.3% | 歷史 |
| TRDAEntrada Therapeutics, Inc. | COM | 110,942 | $114.0 萬 | 0.2% | 歷史 |
| TNYATenaya Therapeutics, Inc. | COM | 1,500,000 | $106.7 萬 | 0.2% | 歷史 |
| CATXPerspective Therapeutics, Inc. | COM NEW | 349,973 | $96.2 萬 | 0.2% | 歷史 |
| JSPRJasper Therapeutics, Inc. | COM NEW | 485,401 | $88.8 萬 | 0.2% | 歷史 |
| PEPGPepGen Inc. | COM | 121,467 | $79.1 萬 | 0.2% | 歷史 |
| OKUROnKure Therapeutics, Inc. | COM CL A | 60,454 | $17.5 萬 | <0.1% | 歷史 |
| MREOMereo BioPharma Group plc | SPON ADS | 255,400 | $10.6 萬 | <0.1% | 歷史 |
| APLTApplied Therapeutics, Inc. | COM | 50,000 | $5,000 | <0.1% | 歷史 |